Switch to:
More From Other Websites
BUZZ-European Pharma: UBS shuffles recommendations Dec 07 2016
Business Watch Dec 07 2016
[$$] Business Watch Dec 06 2016
Novo Nordisk Pledges to Limit Price Increases in U.S. for Its Drugs Dec 06 2016
Novo Nordisk Files Regulatory Application for Semaglutide Dec 06 2016
A second major drugmaker says it will cap price increases Dec 06 2016
A second major drugmaker just committed to limiting price increases Dec 05 2016
Novo's Pricing Pledge Is a Sign of More to Come Dec 05 2016
Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide with the FDA for the Treatment... Dec 05 2016
Novo Nordisk A/S (ADR) (NVO)Hedge Funds Are Snapping Up Dec 05 2016
These drug and medical device companies made $5.6 million in nonresearch payments to Washington... Dec 01 2016
Novo Nordisk A/S: Tresiba® demonstrates a safe cardiovascular profile and reduces the risk of... Dec 01 2016
[$$] Novo Nordisk shares rally on insulin trial results Nov 30 2016
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile Nov 30 2016
Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows Nov 29 2016
Novo Nordisk reports Tresiba insulin achieves target in study Nov 29 2016
Novo Nordisk reports Tresiba insulin achieves target in study Nov 29 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK